Every cell in your body uses the NDUFS4 gene to help mitochondria, the cell’s energy makers, turn food into usable energy. If this gene does not work as it should, cells with high energy needs, especially in the brain and muscles, may struggle to function well. More disruptive variants in the NDUFS4 gene can cause a mitochondrial condition, often Leigh syndrome, which may lead to low muscle tone, movement changes, feeding problems, developmental regression, seizures, or breathing difficulty.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the instructions for proteins, which do much of the cell’s work. Other genes mainly direct when certain processes happen, where they take place, and how strongly they are carried out. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. If you want to go further into this subject, you can find more in the LearnHub.
Overview
NDUFS4Gene function
What if the gene works
The NDUFS4 gene helps build and support complex I, part of the mitochondria, your cells’ energy centers. This helps cells turn food into usable energy, especially in high demand organs like the brain and muscles.
Risk
What if the gene does not work
Variants in the NDUFS4 gene can reduce the cell’s ability to make energy and are a well-established cause of Leigh syndrome and related mitochondrial disease. Milder and more severe variants may influence when symptoms begin and how severe they are.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the NDUFS4 gene does not currently point to a proven, gene-specific medicine or standard drug choice. Treatment is supportive and tailored to the person’s symptoms and organ involvement. The NDUFS4 gene is being studied in experimental work, including gene therapy and other mitochondrial approaches, but these are not established treatments yet.
Conditions associated with NDUFS4
Gene function
What if the gene works
Inside nearly every cell, mitochondria turn food into usable energy. Your cells rely on the NDUFS4 gene to keep one of the first energy making steps in this process running smoothly. This supports a steady supply of energy for normal day to day cell activity.
The NDUFS4 gene makes a small part of complex I, a protein group in mitochondria that starts the cell’s energy pathway. This helps the energy system work as a coordinated unit.
Its protein helps complex I assemble properly and stay stable in the mitochondrial membrane. A well formed complex can carry out energy transfer more smoothly.
By supporting this early mitochondrial step, the NDUFS4 gene helps mitochondria make ATP, the main form of energy cells use. This is part of how the NDUFS4 gene helps mitochondria make energy for everyday cell work.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
NDUFS4 gene variants affect mitochondrial complex I function by making the protein unstable, shortened, or absent, which can impair complex I assembly and reduce cellular energy production. More disruptive variants often leave little or no working protein, while milder variants may allow some residual activity. This functional range can influence whether NDUFS4 related mitochondrial disease, often Leigh syndrome, appears earlier or later and how pronounced its features are. Many disease causing changes act through loss of function.
How variants are linked to conditions
Pathogenic variants in both copies of the NDUFS4 gene cause a form of mitochondrial disease called mitochondrial complex I deficiency, often diagnosed as Leigh syndrome. In studies of conditions linked to NDUFS4 gene variants, the most established association is with early-onset neurologic disease, which may include developmental slowing, low muscle tone, movement problems, and breathing difficulties. This is a confirmed genetic diagnosis rather than a small risk increase.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when several genes and environmental influences also play a role. In other situations, one well-characterized variant in a particular gene is enough to establish the diagnosis.
Are there things that can increase or change my risk?
For NDUFS4, risk is mostly shaped by inheritance rather than lifestyle. A child is at risk of this condition when both parents carry a harmful NDUFS4 change and the child inherits both changed copies; once that genetic pattern is present, there is not enough evidence to say diet, exercise, or other habits lower the chance of developing it.
Inheritance of NDUFS4 variants
Variants in the NDUFS4 gene are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy from each parent, and the parents are typically healthy carriers. When both parents carry an NDUFS4 gene variant, each pregnancy has a 25% chance of resulting in a child with the related condition, a 50% chance of a child who is also a carrier, and a 25% chance of a child who inherits neither variant. In practical terms, the inheritance of NDUFS4 gene variants usually affects brothers and sisters within the same family rather than passing directly from one affected parent to every child.
What does my NDUFS4 result mean for my family?
For families with an NDUFS4-related condition, the pattern is usually recessive, which means parents are often healthy carriers and brothers or sisters could also be affected or be carriers. Close relatives may want to learn whether the same gene change runs in the family, especially if there is a history of early neurologic illness. The implications can matter for future pregnancies as well as for other family members planning children.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the NDUFS4 gene, genetic testing looks at DNA from a blood sample, cheek swab, or saliva sample. Genetic testing for NDUFS4 variants may be done as single gene testing or as part of a broader panel, and a lab compares the gene sequence with the usual code to identify relevant changes.
When should I consider getting a genetic test?
Genetic testing for the NDUFS4 gene may be considered when a child has signs of Leigh syndrome, a serious condition that affects the brain and the body’s energy supply. This can include developmental loss, weak muscle tone, feeding or breathing problems, seizures, or similar symptoms in close relatives.
A genetic result is only one part of your health story
Genetic findings can offer useful insight, but how much they reveal varies by the condition and the specific type of variant. Lifestyle, environment, age, and medical history are among the many factors that shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic results can also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape the way people respond to medications. It looks at connections between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes affect either how strongly a drug works or how the body handles it. This information can support treatment choices that are both better informed and more individualized. To explore this topic in greater depth, you can learn more in the LearnHub.
Drugs influenced by the NDUFS4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how people respond to medicines. Questions about side effects, new symptoms, or whether a treatment is right for you are best discussed with your doctor.
History
NDUFS4 entered medical genetics through research on mitochondrial disease in the late 20th century, as scientists worked to explain why some children developed Leigh syndrome and related energy problems. In recent decades, awareness of this gene’s role has grown as testing improved and more families received a clear genetic answer. Early reports linking pathogenic variants in the NDUFS4 gene to complex I deficiency helped show that some mitochondrial conditions come from genes in the cell nucleus, not only from mitochondrial DNA. That finding was an important step in sorting out a confusing group of inherited conditions with overlapping symptoms. From these first observations, research expanded steadily, and NDUFS4 became a well recognized part of the history of mitochondrial medicine.